Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Department of Surgery, Division of Surgical Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
World J Surg. 2023 Nov;47(11):2800-2808. doi: 10.1007/s00268-023-07157-4. Epub 2023 Sep 13.
Feeding jejunostomy (JT) tubes are often utilized as an adjunct to optimize nutrition for successful esophagectomy; however, their utility has come into question. The aim of this study was to evaluate utilization and outcomes associated with JTs in a nationwide cohort of patients undergoing esophagectomy.
The NSQIP database was queried for patients who underwent elective esophagectomy. JT utilization was assessed between 2010 and 2019. Post-operative outcomes were compared between those with and without a JT on patients with esophagectomy-specific outcomes (2016-2019), with results validated using a propensity score-matched (PSM) analysis based on key clinicopathologic factors, including tumor stage.
Of the 10,117 patients who underwent elective esophagectomy over the past decade, 53.0% had a JT placed concurrently and 47.0% did not. Utilization of JTs decreased over time, accounting for 60.0% of cases in 2010 compared to 41.7% in 2019 (m = - 2.14 95%CI: [- 1.49]-[- 2.80], p < 0.01). Patients who underwent JT had more composite wound complications (17.0% vs. 14.1%, p = 0.02) and a higher rate of all-cause morbidity (40.4% vs. 35.5%, p = 0.01). Following PSM, 1007 pairs were identified. Analysis of perioperative outcomes demonstrated a higher rate of superficial skin infections (6.1% vs. 3.5%, p = 0.01) in the JT group. However, length of stay, reoperation, readmission, anastomotic leak, composite wound complications, all-cause morbidity, and mortality rates were similar between groups.
Among patients undergoing elective esophagectomy, feeding jejunostomy tubes were utilized less frequently over the past decade. Similar perioperative outcomes among matched patients support the safety of esophagectomy without an adjunct feeding jejunostomy tube.
空肠饲管(JT)常作为辅助手段用于优化食管癌切除术患者的营养,但它的实用性受到了质疑。本研究旨在评估全国食管癌患者队列中 JT 的应用和结果。
利用 NSQIP 数据库检索接受择期食管癌切除术的患者。评估 2010 年至 2019 年 JT 的使用情况。对具有 JT 与无 JT 的患者进行食管切除术特异性结局(2016-2019 年)的术后结局比较,并使用基于关键临床病理因素(包括肿瘤分期)的倾向评分匹配(PSM)分析进行结果验证。
在过去十年中,10117 例接受择期食管癌切除术的患者中,53.0%同时放置 JT,47.0%未放置。JT 的使用随着时间的推移而减少,2010 年占 60.0%,2019 年占 41.7%(m=-2.14 95%CI:[-1.49]-[-2.80],p<0.01)。接受 JT 的患者复合伤口并发症更多(17.0% vs. 14.1%,p=0.02),总发病率更高(40.4% vs. 35.5%,p=0.01)。PSM 后,共匹配 1007 对。围手术期结局分析显示,JT 组浅表皮肤感染发生率更高(6.1% vs. 3.5%,p=0.01)。然而,两组的住院时间、再次手术、再入院、吻合口漏、复合伤口并发症、总发病率和死亡率相似。
在接受择期食管癌切除术的患者中,过去十年中 JT 的使用频率有所降低。匹配患者的围手术期结局相似,支持不使用辅助性 JT 进行食管癌切除术的安全性。